BioPharm News

Mar 26, 2018
By BioPharm International Editors
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
Mar 23, 2018
By BioPharm International Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 23, 2018
By BioPharm International Editors
The draft guidance addresses the agency’s policy on evaluating bulk drug substances in drug compounding.
Mar 23, 2018
By BioPharm International Editors
The agency’s Committee for Medicinal Products for Human Use recommended six drugs for approval at its March 2018 meeting.
Mar 22, 2018
By BioPharm International Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 21, 2018
By BioPharm International Editors
AbbVie and the International Myeloma Foundation will partner to study the role of a genetic mutation in outcomes of patients with multiple myeloma.
Mar 20, 2018
By BioPharm International Editors
The agency published two new guidance documents detailing postmarketing safety reporting requirements for combination products.
Mar 20, 2018
By BioPharm International Editors
An expanded pharma services supply chain facility in Germany boosts Thermo Fisher’s Pharma Services footprint in Europe.
Mar 20, 2018
By BioPharm International Editors
ISPE announced BioMarin Pharmaceutical, Shire, Vetter, and Wyeth Pharmaceuticals as FOYA Category winners.
Mar 20, 2018
By BioPharm International Editors
The agency sent a warning letter to Malladi Drugs & Pharmaceuticals Limited after an inspection found CGMP violations that included the presence of vermin.
native1_300x100
lorem ipsum